|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | CA-19-9 ELISA | Angiotensinogen (Intact) ELISA | Deamidated Gliadin IgG ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Mac-2 binding protein (Mac-2bp) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB19124 | 27742 | KAPDTDGLG02 | 27600 | 27362 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme-linked immunoassay (ELISA) for the determination of the Cancer Antigen CA19-9 concentration in human serum or plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Intact Angiotensinogen ELISA in serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures. | Solid phase enzyme immunoassay (ELISA) for the detection of IgG antibodies to deamidated gliadin in human serum. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Solid phase sandwich ELISA for the determination of human Mac-2bp in serum, EDTA-plasma and cell culture media. For research use only, not for use in diagnostic procedures. |
| Detection Target | CA-19-9 | Osteopontin | Intact Proinsulin | Metanephrine / Normetanephrine | Anti-Adalimumab (Humira®) |
| Sample Type | Human serum or plasma. | Blood Plasma, Urine, Cell Culture Media | Serum, EDTA-plasma, and cell culture supernatant. | Urine | Serum and plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 25 - 600 U/mL | 0.28 - 18 ng/mL | 25 to 400 U/mL | 1.56 to 100.0 ng/mL | 0.78 to 100 ng/mL |
| Sensitivity | Inquire | 3.33 ng/mL | 6.83 pg/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 5 ng/mL |
| Assay Time | 1 hour incubation (RT) + 1 hour (RT) + 15 min. (RT) = 2 hours, 15 min. total incubation time. | 2 hours total incubation time. | 1 hr 10 mins (incubation) | 2 hours (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |